Re: Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase 1 clinical trial

Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival

Vaccination therapy in prostate cancer

Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells

Basic overview of current immunotherapy approaches in urologic malignancy

Immunotherapy for prostate cancer: what’s the future?

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trial

Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma

Immuno-gene therapy of cancer with tumour-mRNA transfected dendritic cells